The crackdown is coming in June, according to CEO Bob Iger.
Hemanth Kumar is a freelance writer specializing in science, applied sciences, medicine, and healthcare. His work often focuses on the healthcare system in India and the pharmaceutical landscape, particularly regarding drugs. Hemanth's insights and articles have been featured in prominent publications such as Nature Portfolio, Cureus Journal of Medical Science, MDPI, The Economic Times, Geospatial World, News9 Live, and Paperity.